Apr 7, 2022, 18:01 PM by

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health.

Apr 7, 2022, 18:01 PM by

RNA Solutions is a platform that offers services for the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. CD Genomics is proud to launch the ultralow input RNA-seq service using leading-edge Illumina sequencing techniques.

Apr 7, 2022, 18:00 PM by

Apr 7, 2022, 18:00 PM by

Apr 7, 2022, 18:00 PM by

STEMart launches Acute Systemic Toxicity testing for the medical device industry.

Apr 7, 2022, 18:00 PM by

Amerigo Scientific introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA.

Apr 7, 2022, 18:00 PM by

CD BioSciences introduces a series of Genetic Polymorphism services for the study of GPCR polymorphisms.

Apr 7, 2022, 18:00 PM by

-Absci to present in-silico drug discovery technology at NVIDIA GTC -Breakthrough ML achievements highlight the viability of the computational lead optimization pipeline -Absci collaborates with NVIDIA on research to accelerate and scale in-silico drug discovery platform

Apr 7, 2022, 18:00 PM by

Apr 7, 2022, 17:59 PM by

Qlucore, listed on Nasdaq First North, participates on Redeye Theme Digital Health Day. CEO, Carl-Johan Ivarsson, presents the company at 09:30 and participates in the panel afterwards.

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.

Apr 7, 2022, 17:59 PM by

VERICHEM releases multi-level set of liquid stable and ready-to-use clinical reference materials for the calibration and calibration verification of Ammonia assays with extended shelf-life stability.

Apr 7, 2022, 17:59 PM by

Creative Biogene unveils its comprehensive services of bacterial genome editing for worldwide pharmaceutical partners after the self-optimization of homologous recombination technology and the CRISPR/Cas9 platform.

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

Cambridge, UK – March 29th, 2022 – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence.

Apr 7, 2022, 17:59 PM by

Apr 7, 2022, 17:59 PM by

Leading international events company Easyfairs has opened online registration for Connect in Pharma, the new event for the European pharma and biopharma community. The first edition of the event, taking place on 14 & 15 September 2022, will create a new vision of the future of pharma and biopharma packaging, devices and production.

Apr 7, 2022, 17:59 PM by

CRISPRclean® technology improves single cell transcriptional profiling, enabling scientists to discover and see signals that were previously obscured by abundant genomic sequences

Apr 7, 2022, 17:59 PM by

Alfa Chemistry’s testing branch - T,C&A Lab, has recently announced to provide carbon fiber testing service for customers worldwide. Experts from Alfa Chemistry will offer insights on a series of tests carried out to characterize carbon fiber performance.